| | | |   | | | | By Ed Silverman Ruby Wallau for STAT The company makes the medicines at facilities in New Jersey and Italy. Novartis expects to resume some supplies in the next six weeks. Read More | | By Nicholas Florko Kobi Wolf/Bloomberg Prisons used just a fraction of the antiviral drugs they were allocated to keep incarcerated people from getting ill or dying of Covid. Read More | | By Mohana Ravindranath Screen grab Amid intense scrutiny of its prescribing practices, Cerebral launched a series of advertisements on its ADHD services. Read More | | Sponsor content by CATALENT XPRESS PHARMACEUTICS™ Facilitate adaptive trials and accelerate Phase 1 with an integrated development offering Complete FIH studies 5 to 6 months earlier. Learn how innovative trial designs, on-demand manufacturing, and real-time clinical data-based dose adjustments can enable faster, better decision making during phase 1 clinical trials. Learn more. | | By Damian Garde and Meg Tirrell and Adam Feuerstein This week, we delve into Biogen's twin announcements that the company is pulling the plug on Aduhelm and replacing its embattled CEO. Read More | |
No comments